BioCentury
ARTICLE | Clinical News

Ovarex anti-ideotype vaccine data

April 15, 2013 7:00 AM UTC

At the International Society of Oncodevelopmental Biology and Medicine conference in Montreux, Switzerland, AXO presented data from 100 stage III and IV ovarian cancer patients who had taken Ovarex since 1989. ...